{"id":19694,"date":"2024-05-22T14:02:52","date_gmt":"2024-05-22T14:02:52","guid":{"rendered":"https:\/\/makingpharmaindustry.it\/?p=19694"},"modified":"2024-05-29T09:22:14","modified_gmt":"2024-05-29T09:22:14","slug":"63rd-afi-symposium-interview-with-carla-caramella","status":"publish","type":"post","link":"https:\/\/makingpharmaindustry.it\/en\/afi-interview\/63rd-afi-symposium-interview-with-carla-caramella\/","title":{"rendered":"63rd AFI Symposium \u2013 Carla Caramella&#8217;s interview"},"content":{"rendered":"<p id=\"tw-target-text\" class=\"tw-data-text tw-text-large tw-ta\" dir=\"ltr\" data-placeholder=\"Traduzione\" aria-label=\"Testo tradotto\" data-ved=\"2ahUKEwjHt8CSo6GGAxUt8LsIHRr5BzMQ3ewLegQIBRAU\"><span class=\"Y2IQFc\" lang=\"en\">The <strong>number of people with diabetes continues to grow<\/strong> at an alarming rate, in particular for type 2 diabetes, responsible for over 90% of cases of all forms of diabetes and often associated with other chronic diseases such as obesity, hypertension, dyslipidemia.<\/span><\/p>\n<p dir=\"ltr\" data-placeholder=\"Traduzione\" aria-label=\"Testo tradotto\" data-ved=\"2ahUKEwjHt8CSo6GGAxUt8LsIHRr5BzMQ3ewLegQIBRAU\">Considering this trend, during the <strong>63rd edition of the AFI Symposium<\/strong>, a session will be dedicated to this topic: the Pharmaceutical Sciences Session, in fact, will deal with the <strong>research and development of new therapeutic approaches in the treatment of endocrinological diseases with particular attention to diabetes therapy<\/strong>.<\/p>\n<p class=\"tw-data-text tw-text-large tw-ta\" dir=\"ltr\" data-placeholder=\"Translation\" aria-label=\"Translated text\" data-ved=\"2ahUKEwi-wsCgrKGGAxVQgv0HHXkOBjwQ3ewLegQIBhAU\"><span class=\"Y2IQFc\" lang=\"en\">The session, entitled &#8220;<em>Research, development of new therapeutic approaches in the treatment of diabetes<\/em>&#8220;, <\/span><span class=\"Y2IQFc\" lang=\"en\">will offer an overview of the <strong>clinical, pharmacological and social aspects<\/strong> and will propose <strong>an analysis of technological platforms, portals, chronotherapy and new therapeutic approaches in the treatment of diabetes<\/strong>.<\/span><\/p>\n<p id=\"tw-target-text\" class=\"tw-data-text tw-text-large tw-ta\" dir=\"ltr\" data-placeholder=\"Translation\" aria-label=\"Translated text\" data-ved=\"2ahUKEwi-wsCgrKGGAxVQgv0HHXkOBjwQ3ewLegQIBhAU\"><span class=\"Y2IQFc\" lang=\"en\">Particular emphasis will be given to new and consolidated technologies for controlled drug release and personalized pharmacological therapy in <strong>glycemic control<\/strong>.<\/span><\/p>\n<p id=\"tw-target-text\" class=\"tw-data-text tw-text-large tw-ta\" dir=\"ltr\" data-placeholder=\"Traduzione\" aria-label=\"Testo tradotto\" data-ved=\"2ahUKEwjHt8CSo6GGAxUt8LsIHRr5BzMQ3ewLegQIBRAU\"><span class=\"Y2IQFc\" lang=\"en\">Prof. Carla Caramella introduces the topics of the tenth session of the AFI in the below video interview. In particular, it will clarify why it was decided to dedicate a session to <strong>therapeutic approaches in the treatment of diabetes<\/strong> during the AFI Symposium, what <strong>the most relevant clinical, pharmacological and social aspects<\/strong> generated by new therapeutic approaches are, as well as which they are<strong> new technologies for the controlled release of drugs<\/strong>.<\/span><\/p>\n<p><iframe loading=\"lazy\" title=\"63\u00b0 Simposio AFI_Intervista a Carla Caramella\" width=\"696\" height=\"392\" src=\"https:\/\/www.youtube.com\/embed\/oXW8yzky_eU?feature=oembed\" frameborder=\"0\" allow=\"accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture; web-share\" referrerpolicy=\"strict-origin-when-cross-origin\" allowfullscreen><\/iframe><\/p>\n","protected":false},"excerpt":{"rendered":"<p>The tenth session of the AFI Symposium will be dedicate to the research and development of new therapeutic approaches in the treatment of endocrinological diseases with particular attention to diabetes therapy<\/p>\n","protected":false},"author":32,"featured_media":19700,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"video","meta":{"footnotes":""},"categories":[1065],"tags":[],"class_list":{"0":"post-19694","1":"post","2":"type-post","3":"status-publish","4":"format-video","5":"has-post-thumbnail","7":"category-afi-interview","8":"post_format-post-format-video"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.2 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>63rd AFI Symposium \u2013 Carla Caramella&#039;s interview<\/title>\n<meta name=\"description\" content=\"The X session of the 63\u00b0 AFI Symposium will be dedicate to the new therapeutic approaches in the treatment of diabetes\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/makingpharmaindustry.it\/en\/afi-interview\/63rd-afi-symposium-interview-with-carla-caramella\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"63rd AFI Symposium \u2013 Carla Caramella&#039;s interview\" \/>\n<meta property=\"og:description\" content=\"The X session of the 63\u00b0 AFI Symposium will be dedicate to the new therapeutic approaches in the treatment of diabetes\" \/>\n<meta property=\"og:url\" content=\"https:\/\/makingpharmaindustry.it\/en\/afi-interview\/63rd-afi-symposium-interview-with-carla-caramella\/\" \/>\n<meta property=\"og:site_name\" content=\"MakingPharmaIndustry\" \/>\n<meta property=\"article:published_time\" content=\"2024-05-22T14:02:52+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-05-29T09:22:14+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/makingpharmaindustry.it\/wp-content\/uploads\/2024\/05\/caramella.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1920\" \/>\n\t<meta property=\"og:image:height\" content=\"1080\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Valentina Parrella\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Valentina Parrella\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/makingpharmaindustry.it\/en\/afi-interview\/63rd-afi-symposium-interview-with-carla-caramella\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/makingpharmaindustry.it\/en\/afi-interview\/63rd-afi-symposium-interview-with-carla-caramella\/\"},\"author\":{\"name\":\"Valentina Parrella\",\"@id\":\"https:\/\/makingpharmaindustry.it\/en\/#\/schema\/person\/5e59d6ee887eb3eafd7887d214ff1a09\"},\"headline\":\"63rd AFI Symposium \u2013 Carla Caramella&#8217;s interview\",\"datePublished\":\"2024-05-22T14:02:52+00:00\",\"dateModified\":\"2024-05-29T09:22:14+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/makingpharmaindustry.it\/en\/afi-interview\/63rd-afi-symposium-interview-with-carla-caramella\/\"},\"wordCount\":240,\"image\":{\"@id\":\"https:\/\/makingpharmaindustry.it\/en\/afi-interview\/63rd-afi-symposium-interview-with-carla-caramella\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/makingpharmaindustry.it\/wp-content\/uploads\/2024\/05\/caramella.png\",\"articleSection\":[\"AFI Interview\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/makingpharmaindustry.it\/en\/afi-interview\/63rd-afi-symposium-interview-with-carla-caramella\/\",\"url\":\"https:\/\/makingpharmaindustry.it\/en\/afi-interview\/63rd-afi-symposium-interview-with-carla-caramella\/\",\"name\":\"63rd AFI Symposium \u2013 Carla Caramella's interview\",\"isPartOf\":{\"@id\":\"https:\/\/makingpharmaindustry.it\/en\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/makingpharmaindustry.it\/en\/afi-interview\/63rd-afi-symposium-interview-with-carla-caramella\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/makingpharmaindustry.it\/en\/afi-interview\/63rd-afi-symposium-interview-with-carla-caramella\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/makingpharmaindustry.it\/wp-content\/uploads\/2024\/05\/caramella.png\",\"datePublished\":\"2024-05-22T14:02:52+00:00\",\"dateModified\":\"2024-05-29T09:22:14+00:00\",\"author\":{\"@id\":\"https:\/\/makingpharmaindustry.it\/en\/#\/schema\/person\/5e59d6ee887eb3eafd7887d214ff1a09\"},\"description\":\"The X session of the 63\u00b0 AFI Symposium will be dedicate to the new therapeutic approaches in the treatment of diabetes\",\"breadcrumb\":{\"@id\":\"https:\/\/makingpharmaindustry.it\/en\/afi-interview\/63rd-afi-symposium-interview-with-carla-caramella\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/makingpharmaindustry.it\/en\/afi-interview\/63rd-afi-symposium-interview-with-carla-caramella\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/makingpharmaindustry.it\/en\/afi-interview\/63rd-afi-symposium-interview-with-carla-caramella\/#primaryimage\",\"url\":\"https:\/\/makingpharmaindustry.it\/wp-content\/uploads\/2024\/05\/caramella.png\",\"contentUrl\":\"https:\/\/makingpharmaindustry.it\/wp-content\/uploads\/2024\/05\/caramella.png\",\"width\":1920,\"height\":1080},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/makingpharmaindustry.it\/en\/afi-interview\/63rd-afi-symposium-interview-with-carla-caramella\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/makingpharmaindustry.it\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"63rd AFI Symposium \u2013 Carla Caramella&#8217;s interview\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/makingpharmaindustry.it\/en\/#website\",\"url\":\"https:\/\/makingpharmaindustry.it\/en\/\",\"name\":\"MakingPharmaIndustry\",\"description\":\"Luogo di incontro\u00a0per approfondire e discutere le pi\u00f9 importanti tematiche del mondo Pharma, dalla ricerca e sviluppo al manufacturing, dal mercato al business\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/makingpharmaindustry.it\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/makingpharmaindustry.it\/en\/#\/schema\/person\/5e59d6ee887eb3eafd7887d214ff1a09\",\"name\":\"Valentina Parrella\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/secure.gravatar.com\/avatar\/9489e527cae2d980412b4296f66093487551a8e1010c544334080d6b66e72eeb?s=96&d=mm&r=g\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/9489e527cae2d980412b4296f66093487551a8e1010c544334080d6b66e72eeb?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/9489e527cae2d980412b4296f66093487551a8e1010c544334080d6b66e72eeb?s=96&d=mm&r=g\",\"caption\":\"Valentina Parrella\"},\"url\":\"https:\/\/makingpharmaindustry.it\/en\/author\/valentina-parrella\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"63rd AFI Symposium \u2013 Carla Caramella's interview","description":"The X session of the 63\u00b0 AFI Symposium will be dedicate to the new therapeutic approaches in the treatment of diabetes","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/makingpharmaindustry.it\/en\/afi-interview\/63rd-afi-symposium-interview-with-carla-caramella\/","og_locale":"en_US","og_type":"article","og_title":"63rd AFI Symposium \u2013 Carla Caramella's interview","og_description":"The X session of the 63\u00b0 AFI Symposium will be dedicate to the new therapeutic approaches in the treatment of diabetes","og_url":"https:\/\/makingpharmaindustry.it\/en\/afi-interview\/63rd-afi-symposium-interview-with-carla-caramella\/","og_site_name":"MakingPharmaIndustry","article_published_time":"2024-05-22T14:02:52+00:00","article_modified_time":"2024-05-29T09:22:14+00:00","og_image":[{"width":1920,"height":1080,"url":"https:\/\/makingpharmaindustry.it\/wp-content\/uploads\/2024\/05\/caramella.png","type":"image\/png"}],"author":"Valentina Parrella","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Valentina Parrella","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/makingpharmaindustry.it\/en\/afi-interview\/63rd-afi-symposium-interview-with-carla-caramella\/#article","isPartOf":{"@id":"https:\/\/makingpharmaindustry.it\/en\/afi-interview\/63rd-afi-symposium-interview-with-carla-caramella\/"},"author":{"name":"Valentina Parrella","@id":"https:\/\/makingpharmaindustry.it\/en\/#\/schema\/person\/5e59d6ee887eb3eafd7887d214ff1a09"},"headline":"63rd AFI Symposium \u2013 Carla Caramella&#8217;s interview","datePublished":"2024-05-22T14:02:52+00:00","dateModified":"2024-05-29T09:22:14+00:00","mainEntityOfPage":{"@id":"https:\/\/makingpharmaindustry.it\/en\/afi-interview\/63rd-afi-symposium-interview-with-carla-caramella\/"},"wordCount":240,"image":{"@id":"https:\/\/makingpharmaindustry.it\/en\/afi-interview\/63rd-afi-symposium-interview-with-carla-caramella\/#primaryimage"},"thumbnailUrl":"https:\/\/makingpharmaindustry.it\/wp-content\/uploads\/2024\/05\/caramella.png","articleSection":["AFI Interview"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/makingpharmaindustry.it\/en\/afi-interview\/63rd-afi-symposium-interview-with-carla-caramella\/","url":"https:\/\/makingpharmaindustry.it\/en\/afi-interview\/63rd-afi-symposium-interview-with-carla-caramella\/","name":"63rd AFI Symposium \u2013 Carla Caramella's interview","isPartOf":{"@id":"https:\/\/makingpharmaindustry.it\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/makingpharmaindustry.it\/en\/afi-interview\/63rd-afi-symposium-interview-with-carla-caramella\/#primaryimage"},"image":{"@id":"https:\/\/makingpharmaindustry.it\/en\/afi-interview\/63rd-afi-symposium-interview-with-carla-caramella\/#primaryimage"},"thumbnailUrl":"https:\/\/makingpharmaindustry.it\/wp-content\/uploads\/2024\/05\/caramella.png","datePublished":"2024-05-22T14:02:52+00:00","dateModified":"2024-05-29T09:22:14+00:00","author":{"@id":"https:\/\/makingpharmaindustry.it\/en\/#\/schema\/person\/5e59d6ee887eb3eafd7887d214ff1a09"},"description":"The X session of the 63\u00b0 AFI Symposium will be dedicate to the new therapeutic approaches in the treatment of diabetes","breadcrumb":{"@id":"https:\/\/makingpharmaindustry.it\/en\/afi-interview\/63rd-afi-symposium-interview-with-carla-caramella\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/makingpharmaindustry.it\/en\/afi-interview\/63rd-afi-symposium-interview-with-carla-caramella\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/makingpharmaindustry.it\/en\/afi-interview\/63rd-afi-symposium-interview-with-carla-caramella\/#primaryimage","url":"https:\/\/makingpharmaindustry.it\/wp-content\/uploads\/2024\/05\/caramella.png","contentUrl":"https:\/\/makingpharmaindustry.it\/wp-content\/uploads\/2024\/05\/caramella.png","width":1920,"height":1080},{"@type":"BreadcrumbList","@id":"https:\/\/makingpharmaindustry.it\/en\/afi-interview\/63rd-afi-symposium-interview-with-carla-caramella\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/makingpharmaindustry.it\/en\/"},{"@type":"ListItem","position":2,"name":"63rd AFI Symposium \u2013 Carla Caramella&#8217;s interview"}]},{"@type":"WebSite","@id":"https:\/\/makingpharmaindustry.it\/en\/#website","url":"https:\/\/makingpharmaindustry.it\/en\/","name":"MakingPharmaIndustry","description":"Luogo di incontro\u00a0per approfondire e discutere le pi\u00f9 importanti tematiche del mondo Pharma, dalla ricerca e sviluppo al manufacturing, dal mercato al business","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/makingpharmaindustry.it\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/makingpharmaindustry.it\/en\/#\/schema\/person\/5e59d6ee887eb3eafd7887d214ff1a09","name":"Valentina Parrella","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/9489e527cae2d980412b4296f66093487551a8e1010c544334080d6b66e72eeb?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/9489e527cae2d980412b4296f66093487551a8e1010c544334080d6b66e72eeb?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/9489e527cae2d980412b4296f66093487551a8e1010c544334080d6b66e72eeb?s=96&d=mm&r=g","caption":"Valentina Parrella"},"url":"https:\/\/makingpharmaindustry.it\/en\/author\/valentina-parrella\/"}]}},"_links":{"self":[{"href":"https:\/\/makingpharmaindustry.it\/en\/wp-json\/wp\/v2\/posts\/19694","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/makingpharmaindustry.it\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/makingpharmaindustry.it\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/makingpharmaindustry.it\/en\/wp-json\/wp\/v2\/users\/32"}],"replies":[{"embeddable":true,"href":"https:\/\/makingpharmaindustry.it\/en\/wp-json\/wp\/v2\/comments?post=19694"}],"version-history":[{"count":4,"href":"https:\/\/makingpharmaindustry.it\/en\/wp-json\/wp\/v2\/posts\/19694\/revisions"}],"predecessor-version":[{"id":19769,"href":"https:\/\/makingpharmaindustry.it\/en\/wp-json\/wp\/v2\/posts\/19694\/revisions\/19769"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/makingpharmaindustry.it\/en\/wp-json\/wp\/v2\/media\/19700"}],"wp:attachment":[{"href":"https:\/\/makingpharmaindustry.it\/en\/wp-json\/wp\/v2\/media?parent=19694"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/makingpharmaindustry.it\/en\/wp-json\/wp\/v2\/categories?post=19694"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/makingpharmaindustry.it\/en\/wp-json\/wp\/v2\/tags?post=19694"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}